August 28, 2019 by Steve Blade
A recently compiled report of Fact.MR envisages the global vocal biomarker market to record a spectacular 23.3% CAGR between the forecast period 2018 and 2027. Revenues from global sales of vocal biomarkers are foreseen to surpass US$ 390 Mn by 2027-end. Beyond Verbal, Sonde Health, IBM Corporation, and other leading participants operating in the global vocal biomarker market have been profiled and analyzed in detail in the report.
Demand for vocal biomarkers is primarily driven by mounting incidences of neurological, psychological, and various other ailments that impact speech such as Parkinson’s disease, depression, and attention deficit & disruptive behavior disorders. According to WHO, nearly 350 Mn individuals across the globe suffered from depression in 2016. The Parkinson’s disease Foundation’s estimates slated nearly 10 Mn patients with the disease worldwide in 2016. High prevalence of these disorders are expected to significantly rub off on demand and sales of vocal biomarkers.
Quantification and detection of imperceptible characteristics and subtle changes in the voice can precisely decipher essential aspects of a person’s changing health, including depression, stress and cardiovascular diseases. Accordingly, clinical psychologists and psychoanalysts have been using vocal patterns of patients to assess their personality traits and move further in leaps and bounds in medical and clinical investigations.
Get Free Sample Report Here:
1. Global Vocal Biomarker Market – Executive Summary
2. Global Vocal Biomarker Market Outlook Overview
3. Market Dynamics
Vocal Biomarker Market: Overview
The report offers an up-to-date and comprehensive analysis on vocal biomarker market taking qualitative and quantitative assessment into consideration. The report also elucidates the dynamics of the market such as drivers, restraints, trend and opportunities which have significant impact in the growth of the market. The report peruses into the segregation of market to present a holistic picture of vocal biomarker.
Product development prevails as an imperative strategy driving collaborating between leading companies and research institutes across various sectors, and healthcare is no exception, Apropos of vocal biomarkers, Beyond Verbal has developed “Beyond mHealth Research Platform”, which aims at collaborating with universities, businesses, hospitals, and research institutes for collectively developing unique vocal biomarkers.
Another leading player, Sonde Health Inc., has introduced voice-based technology platform that enables diagnosing and monitoring various conditions and diseases. The company has collaborated with Massachusetts Institute of Technology (MIT) for licensing the technology. Such collaborations and developments will lead to better solutions and more accurate results for patients. It will further encourage researchers and institutions worldwide in collecting voice data for disease diagnostics and improving outcome of patients.
Vocal Biomarker Market: Competitive Scenario
The report also includes Porters’ Five Force Analysis which serves as basis for delineating competitive landscape of vocal biomarker market. Assessing competitiveness becomes imperative to comprehend and anticipate the moves by competitors, for instance. The report includes deep dive analysis with a dashboard view, including product portfolio, financial overview, recent developments and strategies.
Have Any Query?? Ask Our Industry Expert:
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852